NasdaqGM:LMATMedical Equipment
Stronger 2025 Results, Higher Dividend and Buyback Might Change The Case For Investing In LeMaitre Vascular (LMAT)
LeMaitre Vascular, Inc. recently reported fourth-quarter 2025 sales of US$64.45 million and net income of US$15.58 million, alongside full-year 2025 sales of US$249.6 million and net income of US$57.73 million, and announced a higher quarterly dividend of US$0.25 per share plus a share repurchase program of up to US$100 million through February 18, 2027.
In addition, the company issued 2026 guidance that points to higher sales and earnings and plans to highlight its outlook at the Leerink...